Examining the role of Early Neoadjuvant and Synchronous Erbitux in Preoperative Chemo-Radiotherapy using Xeloda followed by Excisional Surgery.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Cetuximab (Primary) ; Capecitabine
- Indications Colorectal cancer
- Focus Adverse reactions
- Acronyms XERXES
- 06 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 06 Oct 2012 Accrual to date is 36% according to United Kingdom Clinical Research Network record.
- 05 Oct 2012 Planned end date changed from 31 Dec 2012 to 1 Apr 2014 as reported by ISRCTN: Current Controlled Trials